drugset / Trial / NCT05464394

Peroperative Administration of Tranexamic Acid in Roux-en-Y Gastric Bypass and One-anastomosis Gastric Bypass

NCT05464394

Phase 3 Unknown 1524 enrolled Franciscus Gasthuis
RandomizedParallel-groupTriple-blindPrevention

Summary

The incidence of bleeding after metabolic surgery seems to increase. The administration of a drug (tranexamic acid) that can reduce bleeding could possibly also reduce bleeding after metabolic surgery. Objective: This study aims to determine whether administration of tranexamic acid before surgery can reduce postoperative bleeding in patients undergoing gastric bypass.

Timeline

Start
2022-09-01
Primary completion
2024-09-01
Completion
2025-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1500 mg Intravenous

Indications